RxDoctor Payments Data

Laura Moyer

Psychiatric/Mental Health, Adult · Chesterland, OHNPI 1902120173

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.6% of the total across 264 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,390 and has fallen 62.4% since, to $522 in 2025.

$4,375in general payments, 2019–2025

Across 264 payments — averaging $16.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$745
  • Lundbeck LLC$669
  • AbbVie$424
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$417
  • Corium, LLC$345
  • Axsome Therapeutics, Inc.$306
  • plus $1K from 16 others

What the payments were for

  • Food & beverage$4,31499%
  • Education$611%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,375 in reported general payments places this provider in the 80th percentile of 42 psychiatric/mental health, adult providers in Ohio.

See all psychiatric/mental health, adult providers in Ohio

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole19$28,777
VraylarCariprazine Hcl13$7,895
Desvenlafaxine Succinate ErDesvenlafaxine Succinate46$3,532
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine41$2,137
Lamotrigine167$2,116
Trazodone Hcl76$1,431
Buspirone Hcl75$1,177
Duloxetine Hcl60$1,122
Aripiprazole41$1,060
Sertraline Hcl103$960
Venlafaxine Hcl ErVenlafaxine Hcl31$798
Bupropion XlBupropion Hcl41$739
Methylphenidate ErMethylphenidate Hcl11$709
Hydroxyzine Hcl17$530
Mirtazapine33$503

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$745$28,77719 claims
AbbVieVraylar$424$7,89513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 42 psychiatric/mental health, adult providers in Ohio.

Other psychiatric/mental health, adult in Chesterland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →